Home › Small Cell Lung Cancer › California › Los Angeles
Pag-aaral pangklinika para sa Small Cell Lung Cancer sa Los Angeles, CA
Isang pag-aaral para sa Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Los Angeles. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- University of California - Los Angeles, Los Angeles
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
Nagre-recruitPhase 3
- GSK Investigational Site, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
- University of Southern California, Los Angeles
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Nagre-recruitPhase 1/2
- START Los Angeles, Los Angeles
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
Nagre-recruitPhase 2
- Valkyrie Clinical Trials, Inc., Los Angeles
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Nagre-recruitPhase 3
- Valkyrie Clinical Trials, Los Angeles
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Nagre-recruitPhase 1/2
- Avenzo Therapeutics Recruiting Site, Los Angeles
- Avenzo Therapeutics Recruiting Site, Los Angeles
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Nagre-recruitPhase 1/2
- University of California LA, Los Angeles
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Nagre-recruitPhase 1/2
- Cedars Sinai Medical Center, Los Angeles
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
Nagre-recruitPhase 1
- University of Southern California, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- The Angeles Clinic and Research Institute, Los Angeles
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Nagre-recruitPhase 3
- UCLA Hematology-Oncology, Los Angeles
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Nagre-recruitPhase 2
- Valkyrie Clinical Trials, Los Angeles
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Nagre-recruitPhase 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Nagre-recruitPhase 1
- University of Southern California, Norris Comprehensive Cancer Center, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Nagre-recruitPhase 1
- Start Lacn, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Nagre-recruit
- Oncology Institute for Hope and Innovation, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
Nagre-recruitPhase 2
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Pag-aaral para sa Small Cell Lung Cancer sa ibang lungsod
- Houston, TX26 pag-aaral
- Arlington, VA23 pag-aaral
- New York City, NY22 pag-aaral
- Boston, MA21 pag-aaral
- Nashville, TN20 pag-aaral
- Orlando, FL15 pag-aaral
- Dallas, TX13 pag-aaral
- Cleveland, OH13 pag-aaral
- Chicago, IL13 pag-aaral
- St. Louis, MO13 pag-aaral
- Detroit, MI12 pag-aaral
- Washington, DC12 pag-aaral
Iba pang pag-aaral sa Los Angeles
- Non-Small Cell Lung Cancer87 pag-aaral
- Kanser (lahat ng uri)74 pag-aaral
- Kanser sa Suso73 pag-aaral
- Kanser sa Prostate61 pag-aaral
- Colorectal Cancer59 pag-aaral
- Metastatic Cancer57 pag-aaral
- Kanser sa Ovary50 pag-aaral
- Kanser sa Baga45 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg42 pag-aaral
- Kanser sa Pancreas35 pag-aaral
- Kanser ng Endometrium34 pag-aaral
- Melanoma34 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.